Pfizer to seek approval for COVID-19 vaccine in kids 5 and up in coming weeks, report says

Pfizer and its partner BioNTech will reportedly soon seek clearance for their COVID-19 vaccine to be used in children 5 and up.

“In the coming weeks, we will present the results of our study on the 5- to 11-year-olds worldwide to the authorities and apply for approval of the vaccine for this age group,” Ozlem Tureci, the chief medical officer of BioNTech, told German publication Der Spiegel in an interview published Friday.

While the Pfizer-BioNTech vaccine was fully approved by the US Food and Drug Administration for people 16 and older last month, it’s still under emergency use authorization for kids 12-15. Pfizer remains the only vaccine authorized for use in kids as young as 12 in the US.

Clinical trials for Moderna and Pfizer vaccines in younger children are underway. On Friday, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Disease, said in an interview with ABC11 that it’s “very likely” COVID vaccines will be available for kids as young as 5 and 6 “as we get into October and early November.”

The data needed for FDA review is expected to be ready by the end of September for Pfizer and in October for Moderna, he added.

As kids return to classrooms with the start of the school year, the US has seen a wave of COVID-19 cases in children, according to the American Academy of Pediatrics. There were over 750,000 new child cases between Aug. 5 and Sept. 2. As of Thursday, 51% of kids 12-15 have received at least one dose of the COVID-19 vaccine and 59% of kids 16-17, according to the AAP…Read more>>


Leave a Reply

Your email address will not be published. Required fields are marked *

Register Form

Email Address
Phone No